AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (August 18, 2005). doi:10.1152/ajpregu.00385.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/R1729    most recent
00385.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warnecke, C.
Right arrow Articles by Regitz-Zagrosek, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warnecke, C.
Right arrow Articles by Regitz-Zagrosek, V.
Submitted on June 1, 2005
Accepted on August 13, 2005

The intronic angiotensin II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing

Christina Warnecke1, Peter Mugrauer2, Daniel Suerder2, Jeanette Erdmann3, Carola Schubert2, and Vera Regitz-Zagrosek2*

1 Charite University Medicine Berlin, and German Heart Institute, Cardiovascular Diesease in Women, Center for Cardiovascular Research, Berlin, Germany; University Erlangen-Nuernberg, Medical Clinic IV/Renal Research Laboratories, Erlangen, Germany
2 Charite University Medicine Berlin, and German Heart Institute, Cardiovascular Diesease in Women, Center for Cardiovascular Research, Berlin, Germany
3 Charite University Medicine Berlin, and German Heart Institute, Cardiovascular Diesease in Women, Center for Cardiovascular Research, Berlin, Germany; University of Schleswig-Holstein, Clinic for Internal Medicine 2, Luebeck, Germany

* To whom correspondence should be addressed. E-mail: vera.regitz-zagrosek{at}charite.de.

The X-linked angiotensin II type 2 receptor (AT2) is supposed to be involved in cardiovascular disorders. Two studies associated the A allele of the AT2 gene polymorphism (PM) 1675 G/A with left ventricular hypertrophy in men and coronary ischemia in women. Since the PM is located in the short intron 1 of the AT2 gene within a sequence motif similar to the splice branch site consensus, we tested whether it might affect pre-mRNA splicing and/or modulate AT2 receptor expression. We first analyzed the AT2 mRNA splice pattern by RT-PCR in myocardial samples from 12 explanted human hearts and compared it with the respective genotypes. All 12 patients, 10 hemizygous males (7 A, 3 G allele carriers) and 2 homozygous females (2 G/G allele carriers), exhibited the same myocardial AT2 splice pattern with a relative abundance of transcript exon 1/2/3 compared with exon 1/3. Next, AT2 minigene constructs were cloned from both alleles, comprising the core promoter and the complete transcribed region up to the translation start codon, upstream of a luciferase reporter gene. These constructs were transfected into human (HT1080) and rat (PC12W) cell lines and rat vascular smooth muscle cells, and luciferase activities were assessed as well as the splice patterns of the chimaeric AT2/luciferase mRNAs. In all transfected cell types the mRNA expressed from the AT2 constructs was spliced like the endogenous myocardial AT2 mRNA. However, luciferase activities driven by the G allele construct were significantly higher than those expressed from the A allele. Taken together these data indicate that individuals carrying the G allele may express higher levels of AT2 receptor protein which may be protective during the development of ventricular hypertrophy and coronary ischemia.




This article has been cited by other articles:


Home page
EuropaceHome page
R. Due-Andersen, T. Hoi-Hansen, C. E. Larroude, N. V. Olsen, J. K. Kanters, F. Boomsma, U. Pedersen-Bjergaard, and B. Thorsteinsson
Cardiac repolarization during hypoglycaemia in type 1 diabetes: impact of basal renin-angiotensin system activity
Europace, July 1, 2008; 10(7): 860 - 867.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. Due-Andersen, U. Pedersen-Bjergaard, T. Hoi-Hansen, N. V. Olsen, C. Kistorp, J. Faber, F. Boomsma, and B. Thorsteinsson
NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system activity
J Appl Physiol, April 1, 2008; 104(4): 1080 - 1085.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
R. Due-Andersen, T. Hoi-Hansen, N. V. Olsen, C. E. Larroude, J. K. Kanters, F. Boomsma, U. Pedersen-Bjergaard, and B. Thorsteinsson
Cardiac repolarization during hypoglycaemia and hypoxaemia in healthy males: impact of renin-angiotensin system activity
Europace, February 1, 2008; 10(2): 219 - 226.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Strauss and A. S. Hall
Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox
Circulation, August 22, 2006; 114(8): 838 - 854.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.